Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00393380 · OUTCOME

Disease-free Survival

Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor · Source last updated 2013-04-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of participants
Interval / dispersion
95% Confidence Interval
Time frame
Measured at 1 year

What was measured

Disease-free survival

Analysis population: 13 patients were transplanted.

Groups in this outcome

Parathyroid Hormone (Teriparatide)

Parathyroid hormone after double umbilical cord blood transplant.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Parathyroid Hormone (Teriparatide)13

Reported measurements

Source class 1
Values in percentage of participants · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Parathyroid Hormone (Teriparatide)38.5Not reported14.162.8Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        14.1
        upper Limit
        62.8
        value
        38.5
denoms
  1. counts
    1. group Id
      OG000
      value
      13
    units
    Participants
description
Disease-free survival
dispersion Type
95% Confidence Interval
groups
  1. description
    Parathyroid hormone after double umbilical cord blood transplant.
    id
    OG000
    title
    Parathyroid Hormone (Teriparatide)
param Type
NUMBER
population Description
13 patients were transplanted.
reporting Status
POSTED
time Frame
Measured at 1 year
title
Disease-free Survival
type
SECONDARY
unit Of Measure
percentage of participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice